Table 2.
Mean of expression levels for assayed miRNAs.
| Control (N = 52) | Osteoarthritis (N = 23) | Fracture (N = 25) | ANOVA p value |
|||
|---|---|---|---|---|---|---|
| Expression levels | Expression levels | Fold change | Expression levels | Fold change | ||
| Hsa-miR-155 | 1.93 ± 1.43 | 0.76 ± 0.45 (a) | − 2.54 | 0.94 ± 0.58 (b) | − 2.05 | 0.00002 |
| Hsa-miR-365 | 0.83 ± 0.61 | 0.31 ± 0.16 (a) | − 2.68 | 0.47 ± 0.31 (c) | − 1.77 | 0.00004 |
| Hsa-miR-423 | 1.25 ± 0.98 | 1.97 ± 1.28 | 1.58 | 2.54 ± 1.69 (c) | 2.03 | 0.0002 |
| Hsa-miR-497 | 0.11 ± 0.08 | 0.38 ± 0.24 (d,e) | 3.45 | 0.18 ± 0.12 (f) | 1.64 | < 0.0000 |
a: p < 0.0000 vs. control.
b: p < 0.001 vs. control.
c: p < 0.01 vs. control.
d: p < 0.0001 vs. control.
e: p < 0.01 vs. fracture.
f: p < 0.05 vs. control.